Axalta Files 8-K as AkzoNobel Launches Notes Offering Backed by Merger Pro Formas
AXTA sits 43% above its 52-week low of $24.937.
Summary
AkzoNobel began a private notes offering today and Axalta furnished the Q3 2026 merger pro forma financials — €10,882 million of combined nine-month revenue and €199 million of pro forma profit — with proceeds potentially refinancing Axalta's notes after the merger closes.
Key Events · M&A and Partnerships · AXTA
-
AkzoNobel Launches Private Notes Offering
Akzo Nobel, Inc., an AkzoNobel subsidiary, began a private notes offering on 2026-11-17 to qualified institutional buyers and non-U.S. persons. Axalta is not the issuer, a guarantor or an offeror of the notes.
-
Pro Forma Combined Financials Furnished
Exhibit 99.1 shows pro forma combined revenue of €10,882 million and profit of €199 million for the nine months ended 2026-09-30, with basic EPS of €0.58 and diluted EPS of €0.57 on 311.2 million weighted average shares.
-
Preliminary Purchase Price Set at €6,414 Million
The preliminary allocation includes €3,315 million of goodwill and €6,748 million of intangible assets; equity consideration is 140 million AkzoNobel shares at an adjusted €45.58 per share.
-
Proceeds May Refinance Axalta Debt Post-Merger
Net proceeds are intended for general corporate purposes and may refinance the 2029 dollar term loans and Axalta's $500 million 2027 notes, $700 million 2029 notes and $500 million 2031 notes following completion.
Analysis · AXTA · Industrial Applications And Services
Why it matters: AkzoNobel kicked off a private notes offering today, and Axalta furnished the Q3 2026 pro forma combined financials so its own investors see the same numbers prospective bond buyers get. For the first time, the pro formas put hard figures on the merger: €10,882 million of combined nine-month revenue, €199 million of pro forma profit, and €6,414 million of preliminary purchase consideration including €3,315 million of goodwill. Axalta is not issuing or guaranteeing the notes, so there is no direct dilution or new Axalta debt here — but the proceeds are earmarked to refinance Axalta's $500 million 2027 notes, $700 million 2029 notes and $500 million 2031 notes after closing, which is the balance-sheet cleanup that precedes completion. The deal still needs remaining regulatory clearances and is targeted for early 2027; the UK CMA flagged competition concerns on 2026-11-11, so that clearance is the open item.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AXTA was trading at $35.75 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7.7B. The 52-week trading range was $24.94 to $38.61. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.